Medplus Health Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
73.00
47.00
117.00
95.00
29.00
22.00
Adjustment
330.00
272.00
187.00
182.00
155.00
117.00
Changes In working Capital
-231.00
-215.00
-102.00
-245.00
-176.00
18.00
Cash Flow after changes in Working Capital
172.00
104.00
203.00
31.00
8.00
159.00
Cash Flow from Operating Activities
143.00
90.00
169.00
2.00
-6.00
146.00
Cash Flow from Investing Activities
-82.00
429.00
-703.00
-34.00
-27.00
-19.00
Cash Flow from Financing Activities
-198.00
-170.00
440.00
-5.00
89.00
-82.00
Net Cash Inflow / Outflow
-137.00
349.00
-92.00
-37.00
55.00
44.00
Opening Cash & Cash Equivalents
228.00
-121.00
-28.00
8.00
-46.00
-91.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
91.00
228.00
-121.00
-28.00
8.00
-46.00
Compare Cash Flow Results of Medplus Health
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
73.44
548.41
-475.00
-86.61%
Adjustment
330.62
114.56
216.00
188.60%
Changes In working Capital
-231.1
-49.8
-182.00
-364.06%
Cash Flow after changes in Working Capital
172.96
613.17
-441.00
-71.79%
Cash Flow from Operating Activities
143.74
483.08
-340.00
-70.25%
Cash Flow from Investing Activities
-82.8
-109.52
27.00
24.40%
Cash Flow from Financing Activities
-198.1
-361.6
163.00
45.22%
Net Cash Inflow / Outflow
-137.17
11.95
-148.00
-1247.87%
Opening Cash & Cash Equivalents
228.38
9.75
219.00
2242.36%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
91.21
21.7
70.00
320.32%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 58.99% vs -46.78% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
143.74
90.41
58.99%